The Next Chapter in Global Healthcare: Trends to Watch

Healthcare is being rewritten in real time. Ageing populations, rising chronic disease burdens, and patients who expect more personalised care are pushing the industry to move faster and think differently. At the centre of this shift sits a simple question: how do we get better therapies to more people, more quickly, without compromising on quality or safety? At the same time, the growing emphasis on healthcare and wellness is shifting the industry's focus from treating illness to improving quality of life and enabling better health outcomes.

As a global pharmaceutical company, Piramal Pharma is contributing to this transformation by partnering with customers across the pharmaceutical value chain, advancing pharmaceutical development, strengthening manufacturing capabilities, and delivering innovative solutions that help improve access to quality healthcare worldwide.

Let’s explore the key trends influencing the future of global healthcare:

Pharmaceutical development timelines have historically been one of the biggest bottlenecks between discovery and patient access. Every stage like discovery chemistry, process development, clinical trial supply, scale-up, and commercial manufacturing adds time, and delays at any single stage can push a therapy's launch back by years.

Piramal Pharma plays an important role in supporting pharmaceutical development through its integrated capabilities across contract development and manufacturing, complex hospital generics, and consumer healthcare. By combining scientific expertise with global manufacturing excellence, the company helps customers bring innovative therapies to patients efficiently and reliably.

Healthcare and wellness are converging into a single conversation. Consumers are no longer thinking about health only in terms of treating illness, they're actively managing prevention, nutrition, and everyday well-being. This has expanded the definition of the pharmaceutical industry's responsibility, from prescription therapies to the over the counter and consumer products people use daily.

This broader perspective is driving demand for innovative medicines, consumer healthcare products, and healthcare solutions that support long-term well-being.

As populations age and chronic diseases become more prevalent, integrating wellness into healthcare strategies will play an increasingly important role in reducing healthcare burdens while improving patient outcomes.

Every global pharmaceutical company has an important role to play in expanding access to quality medicines while advancing scientific innovation.

This includes:

• Investing in research and development
• Expanding global manufacturing capabilities
• Strengthening resilient supply chains
• Leveraging digital technologies
• Collaborating across healthcare ecosystems
• Maintaining the highest standards of quality and compliance

Piramal Pharma contributes to this global effort through its diversified businesses serving customers across more than 100 countries. Its integrated Contract Development and Manufacturing Organization (CDMO) business supports pharmaceutical and biotech companies from early-stage development through commercial manufacturing. Its Complex Hospital Generics business delivers critical care products to hospitals worldwide, while its Consumer Healthcare business provides trusted wellness solutions to millions of consumers.

Together, these capabilities enable Piramal Pharma to support healthcare systems around the world by delivering high-quality products, fostering innovation, and expanding access to care.

The next wave of healthcare innovation is being shaped by technologies that were peripheral a decade ago and are now central: precision and targeted therapies, antibody-drug conjugates, gene and cell therapies, and increasingly sophisticated biologics and vaccine platforms.

Some of the most significant developments include:

• Artificial intelligence for drug discovery and clinical decision support
• Advanced analytics for predictive healthcare
• Digital manufacturing and smart factories
• Continuous manufacturing technologies
• Precision medicine and genomics
• Automation and robotics
• Digital health platforms and remote patient monitoring
• Sustainable manufacturing technologies

These innovations are helping pharmaceutical companies improve efficiency, enhance product quality, reduce development timelines, and deliver therapies more effectively to patients around the world.

As technology continues to evolve, successful healthcare organizations will increasingly combine scientific expertise with digital capabilities to create more connected, efficient, and patient-focused healthcare systems.

The next era of global healthcare will be defined by how well these threads come together. Patient-centric healthcare sets the destination with better outcomes, better access, better experience. Pharmaceutical development capability determines how quickly and reliably the industry can get there. And its companies that treat these as a single, integrated mission rather than separate business lines that will shape what healthcare looks like a decade from now.

Piramal Pharma's approach, spanning CDMO services, complex hospital generics, and consumer healthcare, and guided by its purpose of "Doing well & Doing Good," is a working example of that integration. As global health needs grow more complex, the ability to combine scientific depth, manufacturing scale, and a genuine focus on the patient will be what separates meaningful progress from incremental change.